GBA1 and Parkinson disease: They also demonstrated that in GD subjects without PD-like manifestations, the F-Dopa uptake was decreased in the striatum, with a marked neuronal loss in the tail of the putamen, whereas this reduction was not found in GBA1 heterozygous asymptomatic carriers (Goker-Alpan et al., 2012).